Non-hodgkin Lymphoma

Non-Hodgkin lymphoma (NHL) is a broad term covering more than 60 types of cancer that arise from lymphocytes, white blood cells in the lymphatic system. Unlike Hodgkin lymphoma, NHL has no single defining cell marker, so subtypes vary widely in how they grow, spread, and respond to treatment. Incidence rates in East and Southeast Asia, including Japan, South Korea, and Singapore, have risen steadily over recent decades.

Medicine used to treat Non-hodgkin Lymphoma

Leukeran

Chlorambucil

2 · 5mg

Utilized to manage specific types of blood cancers, formulated to slow the progression of malignant cellular growth in the lymphatic system.

From $3.12 / tablet View

How NHL is treated

Treatment depends heavily on subtype, stage, and how fast the cancer is growing. Slow-growing (indolent) lymphomas are sometimes monitored without immediate treatment; aggressive forms usually require prompt chemotherapy. Alkylating agents such as chlorambucil have a long track record in indolent subtypes, particularly in older or frail patients where tolerability matters. More complex regimens are managed under oncology support protocols that combine multiple agents with supportive care. Seek specialist assessment as soon as enlarged lymph nodes, unexplained weight loss, drenching night sweats, or persistent fatigue arise.